Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06UTT
|
||||
| Former ID |
DNAP001306
|
||||
| Drug Name |
Sphingosomal topotecan
|
||||
| Synonyms |
Inx-0076
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Approved | [1] | ||
| Company |
Inex pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | DNA topoisomerase I | Target Info | Modulator | [1] | |
| WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
| References | |||||
| REF 1 | Plant-derived compounds in clinical trials. Drug Discov Today. 2008 Feb;13(3-4):161-71. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.